Fig. 4From: Secreting-lux/pT-ClyA engineered bacteria suppresses tumor growth via interleukin-1β in two pathwaysSecreting-lux/pT-ClyA engineered bacteria repress tumor growth in vivo. Tumor volumes of the S. typhimurium carrying ClyA (+doxycycline induction) group were smaller compared to other groupsBack to article page